portfolio ↘

A glimpse at
our Portfolio.

Precision medicine for the brain is here. Alto is pioneering an approach to psychiatric drug development which matches the patient with the most promising treatment based on AI-derived brain biomarkers.

Learn more
Korify Capital

Cambrian is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan – the period of life spent in good health.

Learn more
Korify Capital

Refoxy is developing therapeutic medicines intended to treat age-related diseases and improve healthy longevity by focusing on FOXO modulators.

Learn more
Korify Capital

This has just been a glimpse of our portfolio. Click below to discover more.

Discover more
Korify Capital
Korify Capital

Precision medicine for the brain is here. Alto is pioneering an approach to psychiatric drug development which matches the patient with the most promising treatment based on AI-derived brain biomarkers.

Learn more
Korify Capital

Cambrian is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan – the period of life spent in good health.

Learn more
Korify Capital

Refoxy is developing therapeutic medicines intended to treat age-related diseases and improve healthy longevity by focusing on FOXO modulators.

Learn more
Korify Capital

This has just been a glimpse of our portfolio. Click below to discover more.

Discover more
approach ↘

Backing breakthrough technologies in longevity and mental health.

We want people to be able to live long, healthy, and fulfilled lives. Therefore, we aim to back the most promising companies in longevity and mental health, which focus on redefining the sectors as we know them. We form our portoflio by investing in unique approaches led by pioneering teams. Our investment focus is investing in Series A – C rounds into companies that have strong traction, achieved proof of concept, and are positioned to be future leaders in their respective field.

news ↘

Latest
insights.

contact ↘

Get involved
for further information.

Please contact us anytime should you have questions. We are looking forward to getting in touch with you.

Contact Us